tirzepatide and hrt together - Medical Weight Loss | Elite Health Tirzepatide (Zepbound®) & Semaglutide (Wegovy®)

T., Fujimori, K., Urade, Y

Gallbladder disease including cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) has been reported with GLP-1 receptor agonists

You can read more about this in our guide on Semaglutide Fatigue and How to Overcome It

TIRZEPATIDE OVERVIEW Category: Dual GIP and GLP-1 Receptor Agonist How It Works: Tirzepatide selectively activates both the GIP (Glucose-dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-like Peptide 1) receptors, a dual agonism that provides synergistic benefits

In a phase II dose-finding trial, semaglutide was evaluated as an anti-obesity medication, demonstrating superior weight loss efficacy when administered once daily subcutaneously compared to both placebo and once-daily 3.0 mg liraglutide in patients with obesity but without T2DM